tm logo
REGENERON
Live/Registered
REGISTERED AND RENEWED

on 20 Mar 2023

Last Applicant/ Owned by

777 Old Saw Mill River Road

Tarrytown

NY

10591

Serial Number

85596897 filed on 13th Apr 2012

Registration Number

4234151 registered on 30th Oct 2012

in the Principal Register

Correspondent Address

Terrence J. McAllister

Ruggiero McAllister & McMahon LLC

ONE LANDMARK SQUARE

STAMFORD CT 06901

Filing Basis

1. use application currently

Disclaimer

NO DATA

REGENERON

The mark consists of the word "REGENERON" in the color blue in an italic font. Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders The color(s) blue is/are claimed as a feature of the mark.

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders


First Use Date in General

29th Feb 2008

First Use Date in Commerce

29th Feb 2008

Mark Details


Serial Number

No 85596897

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 554.0222UST1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the word "REGENERON" in the color blue in an italic font.

Legal History


Show more

Status DateAction Taken
20th Mar 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
20th Mar 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
20th Mar 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
20th Mar 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02th Sep 2022TEAS SECTION 8 & 9 RECEIVED
14th Jul 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
14th Jul 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14th Jul 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30th Oct 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
24th Oct 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED